FDA
Bendamustine Hydrochloride
The FDA lists this product in 28 strengths and forms.
Composition
- Active ingredients
- BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- BENDAMUSTINE HYDROCHLORIDE 100MG/4ML (25MG/ML) · SolutionNDA219014-001 · Prescription
- BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL · PowderANDA204771-002 · Tentative approval
- BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL · PowderANDA204771-001 · Tentative approval
- BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL · PowderANDA205376-002 · Prescription
- BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL · PowderANDA205376-001 · Prescription
- BENDAMUSTINE HYDROCHLORIDE 100MG/4ML (25MG/ML) · SolutionNDA215033-001 · Prescription
- BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL · PowderANDA205574-002 · Prescription
- BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL · PowderANDA205574-001 · Prescription
- BENDAMUSTINE HYDROCHLORIDE 25MG/VIAL · PowderANDA205447-001 · Discontinued
- BENDAMUSTINE HYDROCHLORIDE 100MG/VIAL · PowderThis page
At a glance
- Brand name
- Bendamustine Hydrochloride
- Route
- Intravenous
- Dosage form
- Powder
- Applicant
- Breckenridge
- Status
- Discontinued
- FDA approval
- 14 Feb 2023
- Application
- ANDA205447-002